SCHEMBL22756578

SCHEMBL22756578

CN1CCN(c2cccc3nccn23)CC1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HTR3E A5X5Y0 3/20 0.45
▸ HTR3B O95264 3/20 0.45
▸ HTR3A P46098 3/20 0.45
▸ HTR3D Q70Z44 3/20 0.45
▸ HTR3C Q8WXA8 3/20 0.45
▸ CDK8 P49336 2/20 0.42
▸ ROCK1 Q13464 2/20 0.42
▸ CHEK1 O14757 1/20 0.42
▸ MAP4K4 O95819 1/20 0.42
▸ CSF1R P07333 1/20 0.42
▸ PRKACA P17612 1/20 0.42
▸ KDR P35968 1/20 0.42
▸ MAP2K1 Q02750 1/20 0.42
▸ ACVR1 Q04771 1/20 0.42
▸ MAP4K2 Q12851 1/20 0.42
▸ DYRK1A Q13627 1/20 0.42
▸ AURKB Q96GD4 1/20 0.42
▸ DYRK1B Q9Y463 1/20 0.42
▸ F10 P00742 1/20 0.42
▸ FLT1 P17948 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21268731 0.81 PLD1 (0.44) CDK8ROCK1CHEK1MAP4K4CSF1R
SCHEMBL30178157 0.81 BRD9 (0.46) CDK8ROCK1CHEK1MAP4K4CSF1R
SCHEMBL30778595 0.78 CDK8 (0.41) CDK8ROCK1CHEK1MAP4K4CSF1R
SCHEMBL24126733 0.78 F10 (0.41) CDK8ROCK1CHEK1MAP4K4CSF1R
Hydrochloric Acid SCHEMBL7099422 0.76 F10 (0.40) CDK8ROCK1CHEK1MAP4K4CSF1R
SCHEMBL7016069 0.75 ALDH1A1 (0.40) CDK8ROCK1CHEK1MAP4K4CSF1R
SCHEMBL30232598 0.74 F10 (0.37) CDK8ROCK1CHEK1MAP4K4CSF1R
SCHEMBL17889457 0.74 PRKCQ (0.40) CDK8ROCK1CHEK1MAP4K4CSF1R
SCHEMBL21268742 0.72 F10 (0.39) CDK8ROCK1CHEK1MAP4K4CSF1R
SCHEMBL5543916 0.72 HTR3A (0.41) HTR3EHTR3BHTR3AHTR3DHTR3C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024092069-A1 CXCR4 INHIBITORS FOR TREATMENT OF NEUROLOGICAL DISEASES X4 PHARMACEUTICALS, INC. (US) 2024-05-02 — — WO disclosed
EP-3808748-A1 SUBSTITUTED PIPERIDINES AS CXCR4-INHIBITORS X4 Pharmaceuticals, Inc. (US) 2021-04-21 — — EP disclosed
EP-3471727-B1 CXCR4 INHIBITORS AND USES THEREOF X4 PHARMACEUTICALS INC (US) 2020-12-09 — — EP disclosed
Send feedback